Seminar: Strategies and updates on patenting inventions relating to personalised medicine in Europe and the US – Basel
Event date: 17th October 2019
HGF is hosting a seminar in Der Teufelhof Basel on Thursday 17th October at 6pm. Partner Dr Leena Contarino and Patent Director Dr Laurence Gainey will consider strategies for patenting inventions in Europe and the US.
Targeted intervention (also known as personalised medicine or precision medicine) is a rapidly evolving field of medicine in which treatments are selected based on the detection of disease markers in individual patients. This enables doctors to prescribe treatment regimens that are tailored to individual patients’ medical needs.
Targeted intervention is already well established modern oncology where new drugs are now often approved together with companion diagnostics used to identify particular markers or genetic mutations in a patient. It is likely that targeted intervention will also become a feature in other therapy areas as the technology evolves. Patenting and enforcing patents covering personalised medicine inventions can be challenging, most notably in the USA.
This seminar will consider strategies for patenting these inventions in Europe and the US, including an update on the evolving situation in the US such as: legislative efforts, USPTO updated guidance and recent court cases such as Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC (Fed. Cir. July 3, 2019).
To register please email [email protected].